1. Home
  2. ALT vs PANL Comparison

ALT vs PANL Comparison

Compare ALT & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • PANL
  • Stock Information
  • Founded
  • ALT 1997
  • PANL 1996
  • Country
  • ALT United States
  • PANL United States
  • Employees
  • ALT N/A
  • PANL N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • ALT Health Care
  • PANL Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • PANL Nasdaq
  • Market Cap
  • ALT 292.0M
  • PANL 328.2M
  • IPO Year
  • ALT N/A
  • PANL N/A
  • Fundamental
  • Price
  • ALT $3.83
  • PANL $5.33
  • Analyst Decision
  • ALT Strong Buy
  • PANL Strong Buy
  • Analyst Count
  • ALT 6
  • PANL 1
  • Target Price
  • ALT $17.40
  • PANL $9.00
  • AVG Volume (30 Days)
  • ALT 3.0M
  • PANL 222.3K
  • Earning Date
  • ALT 08-12-2025
  • PANL 08-07-2025
  • Dividend Yield
  • ALT N/A
  • PANL 3.75%
  • EPS Growth
  • ALT N/A
  • PANL N/A
  • EPS
  • ALT N/A
  • PANL 0.16
  • Revenue
  • ALT $20,000.00
  • PANL $579,781,169.00
  • Revenue This Year
  • ALT N/A
  • PANL $13.00
  • Revenue Next Year
  • ALT $761,880.20
  • PANL N/A
  • P/E Ratio
  • ALT N/A
  • PANL $33.08
  • Revenue Growth
  • ALT N/A
  • PANL 15.10
  • 52 Week Low
  • ALT $2.90
  • PANL $3.93
  • 52 Week High
  • ALT $11.16
  • PANL $7.50
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • PANL 59.78
  • Support Level
  • ALT $3.35
  • PANL $5.21
  • Resistance Level
  • ALT $3.66
  • PANL $5.48
  • Average True Range (ATR)
  • ALT 0.19
  • PANL 0.16
  • MACD
  • ALT 0.07
  • PANL 0.03
  • Stochastic Oscillator
  • ALT 86.18
  • PANL 75.81

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: